Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Hardman & Co Research: The Fulham Shore (Initiation of coverage): Platform ready for take-off
Hardman & Co Research: The Fulham Shore (Initiation of coverage): Platform ready for take-off
Hardman & Co Research: The Fulham Shore (Initiation of coverage): Platform ready for take-off
Rights and Issues Investment Trust PLC: Appointment of Corporate Broker
Rights and Issues Investment Trust PLC: Appointment of Corporate Broker
Rights and Issues Investment Trust PLC: Appointment of Corporate Broker
SThree: Total Voting Rights
SThree: Total Voting Rights
SThree: Total Voting Rights
Rights and Issues Investment Trust PLC: Half Year Report for the period to 30th June 2022
Rights and Issues Investment Trust PLC: Half Year Report for the period to 30th June 2022
Rights and Issues Investment Trust PLC: Half Year Report for the period to 30th June 2022
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Total Voting Rights
Rights and Issues Investment Trust PLC: Total Voting Rights
Rights and Issues Investment Trust PLC: Total Voting Rights
Invitation Half-Year 2022 Results Media and Investor Conference Call and Webcast
Invitation Half-Year 2022 Results Media and Investor Conference Call and Webcast
Invitation Half-Year 2022 Results Media and Investor Conference Call and Webcast
Halfords Group PLC: Director/PDMR Shareholding
Halfords Group PLC: Director/PDMR Shareholding
Halfords Group PLC: Director/PDMR Shareholding
Aroundtown SA: Release of a capital market information
Aroundtown SA: Release of a capital market information
Aroundtown SA: Release of a capital market information
DGAP-News: Medios AG: Contract of CEO Matthias Gaertner extended ahead of schedule
DGAP-News: Medios AG: Contract of CEO Matthias Gaertner extended ahead of schedule
DGAP-News: Medios AG: Contract of CEO Matthias Gaertner extended ahead of schedule
KYOCERA Announces Consolidated Financial Results for Three Months Ended June 30, 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24000/Kyocera_logo.svg.png
KYOCERA Announces Consolidated Financial Results for Three Months Ended June 30, 2022


Kyocera Corporation (TOKYO:6971) today announced its consolidated financial results for the three months ended June 30, 2022 (the “first quarter,” or “FY23-Q1”), as summarized below. Complete

Ergomed (ERGO): Sustained growth momentum in H122
Ergomed (ERGO): Sustained growth momentum in H122
Ergomed (ERGO): Sustained growth momentum in H122
Bloc Ventures: Demand for deep tech unhindered by downturn
Bloc Ventures: Demand for deep tech unhindered by downturn
Bloc Ventures: Demand for deep tech unhindered by downturn
MD Medical Group Investments Plc: MD Medical Group announces operating results for Q2 2022
MD Medical Group Investments Plc: MD Medical Group announces operating results for Q2 2022
MD Medical Group Investments Plc: MD Medical Group announces operating results for Q2 2022
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
DGAP-News: UniDevice AG: Month Sales Record
DGAP-News: UniDevice AG: Month Sales Record
DGAP-News: UniDevice AG: Month Sales Record
DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Presents Preclinical Evidence of Combination Therapy Potential for Varoglutamstat in AD at AAIC 2022
DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Presents Preclinical Evidence of Combination Therapy Potential for Varoglutamstat in AD at AAIC 2022
DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Presents Preclinical Evidence of Combination Therapy Potential for Varoglutamstat in AD at AAIC 2022
DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Presents Key Phase 2b Data at AAIC 2022 Showing that Varoglutamstat is Well Tolerated at Doses with High Target Inhibition, Highlighting Unique O
DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Presents Key Phase 2b Data at AAIC 2022 Showing that Varoglutamstat is Well Tolerated at Doses with High Target Inhibition, Highlighting Unique O
DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Presents Key Phase 2b Data at AAIC 2022 Showing that Varoglutamstat is Well Tolerated at Doses with High Target Inhibition, Highlighting Unique O
DGAP-News: Dermapharm commits to acquire the French market leader for herbal medicinal products and food supplements
DGAP-News: Dermapharm commits to acquire the French market leader for herbal medicinal products and food supplements
DGAP-News: Dermapharm commits to acquire the French market leader for herbal medicinal products and food supplements
DGAP-Adhoc: Dermapharm Holding SE: binding offer to acquire Arkopharma Group
DGAP-Adhoc: Dermapharm Holding SE: binding offer to acquire Arkopharma Group
DGAP-Adhoc: Dermapharm Holding SE: binding offer to acquire Arkopharma Group
Independent Bank Group, Inc. Appoints Paul Langdale as Chief Financial Officer: https://mms.businesswire.com/media/20210405005114/en/869069/5/4969461_IFBankGroup_Logo_S_4C.jpg
Independent Bank Group, Inc. Appoints Paul Langdale as Chief Financial Officer


Independent Bank Group, Inc. (NASDAQ: IBTX) today announced the appointment of Paul Langdale as Chief Financial Officer. Mr. Langdale is replacing Michelle Hickox, who has served as Chief Financial

Fifth Third Bancorp Announces Earnings Release Dates for 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24455/Fifth_Third_Bank.svg_%281%29.png
Fifth Third Bancorp Announces Earnings Release Dates for 2023


Fifth Third Bancorp (Nasdaq: FITB) is expected to report financial results and host conference calls to discuss results on the following dates:




  • Thursday, January 19, 2023 – Fourth Quarter 2022

First Business Bank Declares Quarterly Cash Dividends: https://mms.businesswire.com/media/20200123005785/en/686659/5/Fb_logo.jpg
First Business Bank Declares Quarterly Cash Dividends


First Business Financial Services, Inc. (the “Company”, the “Bank”, or “First Business Bank”) (Nasdaq: FBIZ) announced its board of directors has declared a quarterly cash dividend on its common

American Equity Declares 3rd Quarter 2022 Preferred Stock Dividends: https://mms.businesswire.com/media/20191106005918/en/643514/5/AE_HOLDING_Full_size_logo_-_Blue.jpg
American Equity Declares 3rd Quarter 2022 Preferred Stock Dividends


American Equity Investment Life Holding Company (NYSE: AEL), today announced that in accordance with the terms of its 5.95% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series A (the “Series A

Keysight Enables Global Certification Forum to Activate Certification of 5G Devices in Accordance with 3GPP Release 16 Specifications: https://mms.businesswire.com/media/20191105005173/en/754303/5/Keysight_Signature_Pref_Color.jpg
Keysight Enables Global Certification Forum to Activate Certification of 5G Devices in Accordance with 3GPP Release 16 Specifications


Keysight Technologies, Inc. (NYSE: KEYS), a leading technology company that delivers advanced design and validation solutions to help accelerate innovation to connect and secure the world, has